Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 10—October 2007

Dispatch

Ciprofloxacin-Resistant Neisseria meningitidis, Delhi, India

Smita Singhal*, Kedar P. Purnapatre*, Vandana Kalia*, Smita Dube*, Deepti Nair†, Monorama Deb†, Pushpa Aggarwal‡, Sunil Gupta§, Dilip J. Upadhyay*, Awdhesh Kalia¶, and V. Samuel Raj*Comments to Author 
Author affiliations: *Ranbaxy Research Laboratories, Gurgaon, India; †Vardhman Mahaveer Medical College and Safdarjung Hospital, New Delhi, India; ‡Ministry of Health and Family Welfare, New Delhi, India; §National Institute of Communicable Diseases, Delhi, India; ¶Caribbean Epidemiology Centre, Port of Spain, Trinidad and Tobago;

Main Article

Table

Antimicrobial susceptibility pattern of Neisseria meningitidis isolates from the recurrent outbreak during January– March 2006, Delhi, India*

Isolate MIC (μg/mL)
PEN CRO RIF CIP GAT MXF LVX SPX NOR NAL
SFDJ M-1 0.125 0.008 0.004 0.125 0.03 0.125 0.125 0.06 0.125 >16
SFDJ M-2 0.125 0.008 0.004 0.25 0. 25 0.125 0.03 0.06 0.25 >16
SFDJ 691 0.03 <0.001 0.125 0.25 0.25 0.5 0.25 0.25 0.5 >16
SFDJ 306 0.03 0.008 0.008 0.125 0.06 0.125 0.25 0.06 0.25 >16
SFDJ 651 0.06 0.002 0.03 0. 5 0.125 0.25 0.25 0.125 0.5 >16
SFDJ 568 0.125 0.002 0.06 0.25 0.125 0.25 0.25 0.125 0.5 >16
SFDJ 668 0.06 0.002 0.06 0.25 0.125 0.25 0.125 0.125 0.25 >16
SFDJ 270 0.125 0.008 0.015 0.125 0.06 0.125 0.125 0.125 0.25 >16
SFDJ MA-3 0.06 0.004 0.125 0.5 0.25 0.25 1 1 1 >16
SFDJ 339 0.125 <0.001 0.25 0.25 0.25 0.25 0.25 0.25 0.25 >16
SFDJ 58 0.125 0.008 0.004 0.125 0.06 0.125 0.03 0.06 0.25 >16

*PEN, penicillin; CRO, ceftriaxone; RIF, rifampin; CIP, ciprofloxacin; GAT, gatifloxacin; MFX, moxifloxacin; LVX, levofloxacin; SPX, sparfloxacin; NOR, norfloxacin; NAL, nalidixic acid.

Main Article

TOP